Albert Bourla - Sep 12, 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
Susan E. Grant, by power of atty., for Albert Bourla
Stock symbol
PFE
Transactions as of
Sep 12, 2024
Transactions value $
$527
Form type
4
Date filed
9/16/2024, 01:11 PM
Previous filing
Sep 3, 2024
Next filing
Oct 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Disposed to Issuer $0 -413K -100% $0.00 0 Sep 12, 2024 Common Stock 413K $42.30 Direct F1
transaction PFE Stock Appreciation Rights Award $0 +413K $0.00 413K Sep 12, 2024 Common Stock 413K $42.30 Direct F1, F2
transaction PFE Stock Appreciation Rights Disposed to Issuer $0 -412K -100% $0.00 0 Sep 12, 2024 Common Stock 412K $45.96 Direct F1
transaction PFE Stock Appreciation Rights Award $0 +412K $0.00 412K Sep 12, 2024 Common Stock 412K $45.96 Direct F1, F2
transaction PFE Phantom Stock Units SSP Award $527 +18 +0% $29.27 679K Sep 13, 2024 Common Stock 18 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.
F2 Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged.
F3 Each unit represents one phantom share of common stock.
F4 These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.